文献速递运动医学

利用肩峰下撞击小鼠模型评估新型治疗药物对肩袖肌腱病炎症反应的调节作用

Evaluation of Novel Therapeutic Agents for Modulation of the Inflammatory Response in Rotator Cuff Tendinopathy Utilizing a Mouse Model of Subacromial Impingement.
PubMed 文献 · Am J Sports Med · 2025-03-30

在90只12周龄雄性C57BL/6J小鼠的肩峰下撞击模型中,比较氯沙坦、阿那白滞素、α-2-巨球蛋白与皮质类固醇注射及未治疗对照的效果。流式细胞术显示治疗组基质细胞标志物谱更接近假手术对照,基因表达分析显示治疗组细胞因子信号、炎症小体、吞噬细胞功能、氧化应激和蛋白毒性应激通路评分显著低于撞击对照。结论认为这些新型治疗药物可能有助于促进基质祖细胞的有利环境并减少炎症和应激通路。

要点

  • 治疗组CD51+、CD73+、CD90.2+、CD105+和CD146+细胞百分比较撞击对照组显著更高。
  • 治疗组细胞因子信号、炎症小体、吞噬细胞功能、氧化应激和蛋白毒性应激通路评分显著低于撞击对照组。
  • 这些新型治疗药物可能有助于为基质祖细胞创造有利环境并减少炎症反应。

核心结论

  • 这些新型治疗药物可能有助于促进基质祖细胞的有利环境,并减少与肩峰下撞击相关的细胞因子信号、炎症反应和应激通路。

研究设计与样本

  • 控制实验室研究,共90只12周龄雄性C57BL/6J小鼠分为6组,每组15只。
  • 第1组为假手术无治疗对照,第2组为双侧肩部放置金属夹诱导肩袖撞击但未进一步治疗,第3-6组在第0天行双侧金属夹撞击手术并在第21天分别接受肩峰下注射皮质类固醇、阿那白滞素或α-2-巨球蛋白,或通过饮水给予氯沙坦。
  • 所有小鼠在初始撞击手术后6周处死,取冈上肌腱和肌肉进行组织学、生物力学测试、流式细胞术、基因表达和步态分析,显著性水平设为P = .05。

主要发现

  • 流式细胞术显示治疗组的基质细胞标志物谱更接近假手术对照而非撞击对照,治疗组CD51+、CD73+、CD90.2+、CD105+和CD146+细胞百分比较撞击对照组显著更高。
  • 基因表达分析显示治疗组细胞因子信号、炎症小体、吞噬细胞功能、氧化应激和蛋白毒性应激通路评分较撞击对照组显著降低。

临床怎么用

  • 作者认为这些新型治疗药物可能有助于为基质祖细胞创造有利环境并减少炎症和应激通路,进一步研究这些药物及炎症的细胞和分子机制可能允许使用皮质类固醇注射的替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotator cuff disease is prevalent and can cause significant disability. Local subacromial corticosteroid injections (CSIs) have been a mainstay of nonoperative management despite concerns regarding their potential for adverse effects on tendon and muscle tissue. We identified 3 potential molecular targets that could be inhibited by alternative, currently available treatments. PURPOSE: To compare the effects of losartan (LOS), anakinra (AK), and alpha-2-macroglobulin (A2M), not previously utilized in the treatment of rotator cuff disease, with CSI-treated and nontreated controls in a murine model of rotator cuff tendinopathy. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 90 twelve-week-old male C57BL/6J mice were placed into 6 different groups (n = 15 mice per group). Group 1 underwent a sham procedure with no treatment (sham controls). Group 2 underwent placement of a metal clip in bilateral shoulders to induce impingement on the rotator cuff but received no further treatment. All mice receiving treatments (groups 3-6) underwent bilateral clip impingement surgery on day 0. On day 21, subacromial injections of CSI, AK, or A2M were performed, and LOS was administered via drinking water. All mice were sacrificed at 6 weeks after the initial impingement surgery. The supraspinatus tendons and muscles were harvested. Histology, biomechanical testing, flow cytometry, gene expression, and gait analysis were performed. The significance level was set at P = .05 for all statistical analyses. RESULTS: Flow cytometry demonstrated that treatment groups exhibited individual stromal cell marker profiles more similar to sham controls than to the impingement control groups, with significantly higher percentages of CD51+, CD73+, CD90.2+, CD105+, and CD146+ cells compared with the impingement control group. Gene expression analysis demonstrated significantly decreased pathway scores for cytokine signaling, inflammasome, phagocytic cell function, oxidative stress, and proteotoxic stress in the treatment groups compared with the impingement control group. CONCLUSION: These novel therapeutic agents may have utility in promoting a favorable environment for stromal progenitor cells and decreasing cytokine signaling, inflammatory responses, and stress pathways associated with subacromial impingement. CLINICAL RELEVANCE: Further investigation into these agents and the underlying cellular and molecular mechanisms of inflammation may allow for the utilization of alternatives to CSIs.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Eliasberg CD, Carballo CB, J H Yao V, et al. Evaluation of Novel Therapeutic Agents for Modulation of the Inflammatory Response in Rotator Cuff Tendinopathy Utilizing a Mouse Model of Subacromial Impingement. Am J Sports Med. 2025. PMID: 40159684. doi:10.1177/03635465251330008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。